Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin

BACKGROUND: Hydroxychloroquine and azithromycin combination therapy is often prescribed for coronavirus disease 2019 (COVID-19). Electrocardiographic (ECG) monitoring is warranted because both medications cause corrected QT-interval (QTc) prolongation. Whether QTc duration significantly varies durin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Cardiol
Autores principales: Cipriani, Alberto, Zorzi, Alessandro, Ceccato, Davide, Capone, Federico, Parolin, Matteo, Donato, Filippo, Fioretto, Paola, Pesavento, Raffaele, Previato, Lorenzo, Maffei, Pietro, Saller, Alois, Avogaro, Angelo, Sarais, Cristiano, Gregori, Dario, Iliceto, Sabino, Vettor, Roberto
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier B.V. 2020
Materias:
Short Communication
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7235573/
https://ncbi.nlm.nih.gov/pubmed/32439366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcard.2020.05.036
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares